Gene · 8405
Papers2,215
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,215
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A systematic pan-cancer analysis identifies TRIM28 as an immunological and prognostic predictor and involved in immunotherapy resistance. | J Cancer | 2023 | 37781084 | PubTator, text mining | PubMed |
| Multiomic prediction of therapeutic targets for human diseases associated with protein phase separation. | Proc Natl Acad Sci U S A | 2023 | 37774095 | PubTator, text mining | PubMed |
| A cellular senescence-related genes model allows for prognosis and treatment stratification of cervical cancer: a bioinformatics analysis and external verification. | Aging (Albany NY) | 2023 | 37768206 | PubTator, text mining | PubMed |
| Emerging Roles of Ubiquitination in Biomolecular Condensates. | Cells | 2023 | 37759550 | PubTator, text mining | PubMed |
| RIG-I promotes immune evasion of colon cancer by modulating PD-L1 ubiquitination. | J Immunother Cancer | 2023 | 37758653 | PubTator, text mining | PubMed |
| Prognostic significance of TP53 and PIK3CA mutations analyzed by next-generation sequencing in breast cancer. | Medicine (Baltimore) | 2023 | 37747019 | PubTator, text mining | PubMed |
| Methylation of BRD4 by PRMT1 regulates BRD4 phosphorylation and promotes ovarian cancer invasion. | Cell Death Dis | 2023 | 37737256 | PubTator, text mining | PubMed |
| FBXW2 suppresses breast tumorigenesis by targeting AKT-Moesin-SKP2 axis. | Cell Death Dis | 2023 | 37736741 | PubTator, text mining | PubMed |
| Pervasive mislocalization of pathogenic coding variants underlying human disorders. | bioRxiv | 2023 | 37732209 | PubTator, text mining | PubMed |
| The heterogeneity and clonal evolution analysis of the advanced prostate cancer with castration resistance. | J Transl Med | 2023 | 37726835 | PubTator, text mining | PubMed |
| Liquid‒liquid phase separation: roles and implications in future cancer treatment. | Int J Biol Sci | 2023 | 37705755 | PubTator, text mining | PubMed |
| Transposable Elements Are Co-opted as Oncogenic Regulatory Elements by Lineage-Specific Transcription Factors in Prostate Cancer. | Cancer Discov | 2023 | 37694973 | PubTator, text mining | PubMed |
| Lineage Plasticity and Stemness Phenotypes in Prostate Cancer: Harnessing the Power of Integrated "Omics" Approaches to Explore Measurable Metrics. | Cancers (Basel) | 2023 | 37686633 | PubTator, text mining | PubMed |
| Pre-Clinical Models to Study Human Prostate Cancer. | Cancers (Basel) | 2023 | 37686488 | PubTator, text mining | PubMed |
| The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19. | Int J Mol Sci | 2023 | 37686182 | PubTator, text mining | PubMed |
| CircXRN2 suppresses tumor progression driven by histone lactylation through activating the Hippo pathway in human bladder cancer. | Mol Cancer | 2023 | 37684641 | PubTator, text mining | PubMed |
| The potential role of CDC20 in tumorigenesis, cancer progression and therapy: A narrative review. | Medicine (Baltimore) | 2023 | 37682144 | PubTator, text mining | PubMed |
| Opposing Roles of SPOP Mutations in Human Prostate and Endometrial Cancers. | JCO Precis Oncol | 2023 | 37677121 | PubTator, text mining | PubMed |
| Commentary: Genomic, epigenomic, and transcriptomic signatures of prostate cancer between African American and European American patients. | Front Oncol | 2023 | 37675223 | PubTator, text mining | PubMed |
| HER-2 ultra-low breast cancer: exploring the clinicopathological features and prognosis in a retrospective study. | Front Oncol | 2023 | 37664018 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8405/papers?page=15